Legal & General Group Plc Boosts Holdings in Tempus AI, Inc. (NASDAQ:TEM)

Legal & General Group Plc lifted its stake in shares of Tempus AI, Inc. (NASDAQ:TEM) by 40.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 358,432 shares of the company’s stock after purchasing an additional 103,464 shares during the period. Legal & General Group Plc owned about 0.23% of Tempus AI worth $12,101,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of TEM. Envestnet Asset Management Inc. boosted its holdings in Tempus AI by 157.7% in the 4th quarter. Envestnet Asset Management Inc. now owns 44,119 shares of the company’s stock worth $1,489,000 after buying an additional 26,998 shares during the last quarter. Wells Fargo & Company MN raised its stake in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock valued at $80,000 after purchasing an additional 278 shares during the last quarter. ExodusPoint Capital Management LP purchased a new position in Tempus AI in the 4th quarter valued at $1,916,000. Massachusetts Financial Services Co. MA acquired a new stake in Tempus AI during the 4th quarter worth $10,148,000. Finally, StoneX Group Inc. purchased a new stake in shares of Tempus AI during the fourth quarter worth $527,000. Institutional investors and hedge funds own 24.22% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on TEM shares. Morgan Stanley raised their price target on shares of Tempus AI from $50.00 to $60.00 and gave the stock an “overweight” rating in a research note on Thursday, March 6th. Loop Capital decreased their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Piper Sandler dropped their price target on Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. Wolfe Research cut Tempus AI from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 26th. Finally, TD Cowen reissued a “buy” rating and set a $74.00 price objective (up previously from $58.00) on shares of Tempus AI in a research note on Wednesday, February 5th. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $61.18.

Tempus AI Stock Down 4.8 %

NASDAQ TEM opened at $40.86 on Thursday. The stock has a fifty day simple moving average of $54.66 and a 200-day simple moving average of $50.71. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a twelve month low of $22.89 and a twelve month high of $91.45.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, Director Jennifer A. Doudna sold 1,320 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $90.00, for a total value of $118,800.00. Following the sale, the director now owns 36,011 shares of the company’s stock, valued at $3,240,990. The trade was a 3.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Eric P. Lefkofsky sold 80,003 shares of the firm’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $85.78, for a total value of $6,862,657.34. Following the transaction, the chief executive officer now owns 5,049,460 shares of the company’s stock, valued at approximately $433,142,678.80. This represents a 1.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,411,249 shares of company stock valued at $310,486,558 over the last 90 days.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.